168 related articles for article (PubMed ID: 21084937)
21. Familial ovarian cancer screening.
Stirling D; Porteous ME; Evans DG; Pichert G; Steel M
J Clin Oncol; 2006 Feb; 24(6):e11. PubMed ID: 16484689
[No Abstract] [Full Text] [Related]
22. Diagnostic markers for ovarian cancer screening: not ready for routine clinical use.
Coates RJ; Kolor K; Stewart SL; Richardson LC
Clin Cancer Res; 2008 Nov; 14(22):7575-6; author reply 7577-9. PubMed ID: 18948387
[No Abstract] [Full Text] [Related]
23. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
24. [Expression of CA-125 in ovarian cancer].
Mircea R; Frîncu DL; Dumitrache F
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1191-4. PubMed ID: 20191897
[TBL] [Abstract][Full Text] [Related]
25. Screening for ovarian cancer: is it worth the risk?
Bell R
Nurs Times; 1999 Jan 20-26; 95(3):52-3. PubMed ID: 10076394
[TBL] [Abstract][Full Text] [Related]
26. Can cancer be diagnosed with a blood test during routine examinations?
Weiss PA; Weiss PA
Clin J Oncol Nurs; 2007 Dec; 11(6):940-1. PubMed ID: 18063553
[TBL] [Abstract][Full Text] [Related]
27. [Combined use of tumor markers and MRI tomography in differential diagnosis of ovarian neoplasms].
Pavlov SB; Akulina EA; Pavlova GB
Klin Med (Mosk); 1999; 77(4):49-51. PubMed ID: 10356919
[TBL] [Abstract][Full Text] [Related]
28. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of benign pelvic mass with high serum levels of CA(125)].
Zhang X; Wu LY; Li XJ; Li HJ; Zhang R; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2005 Mar; 40(3):178-82. PubMed ID: 15840313
[TBL] [Abstract][Full Text] [Related]
30. [Ovarian cancer screening in the general population].
Mathevet P; Delaloye JF
Rev Med Suisse; 2013 Oct; 9(403):1943-4, 1946-9. PubMed ID: 24245016
[TBL] [Abstract][Full Text] [Related]
31. CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC/EORTC CA-125 Surveillance Trial.
Markman M; Petersen J; Belland A; Burg K
Oncology; 2010; 78(1):1-2. PubMed ID: 20215782
[No Abstract] [Full Text] [Related]
32. [Tumor markers in epithelial ovarian cancer].
Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G
Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857
[TBL] [Abstract][Full Text] [Related]
33. [Tumor marker in ovarian cancer].
Komai K; Nishida T
Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
[TBL] [Abstract][Full Text] [Related]
34. CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer.
Oehler MK; Sütterlin M; Caffier H
Anticancer Res; 1999; 19(4A):2513-8. PubMed ID: 10470185
[TBL] [Abstract][Full Text] [Related]
35. Elevated Serum CA-125 concentration in a patient with tuberculous peritonitis mimicking ovarian cancer.
Kucok M
J Reprod Med; 1998 Jul; 43(7):635-6. PubMed ID: 9693414
[No Abstract] [Full Text] [Related]
36. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
[TBL] [Abstract][Full Text] [Related]
37. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer.
Sliutz G; Tempfer C; Kainz C; Mustafa G; Gitsch G; Koelbl H; Biegelmayer C
Anticancer Res; 1995; 15(3):1127-9. PubMed ID: 7645936
[TBL] [Abstract][Full Text] [Related]
38. Early diagnosis of ovarian carcinoma: is a solution in sight?
Lutz AM; Willmann JK; Drescher CW; Ray P; Cochran FV; Urban N; Gambhir SS
Radiology; 2011 May; 259(2):329-45. PubMed ID: 21502390
[TBL] [Abstract][Full Text] [Related]
39. [Comparative evaluation of diagnostic significance of carbohydrate antigen CA125 and cancer-embryonal antigen in ovarian cancer].
Lapchenkov VI; Dudarev AL; Vinokurov VL; Iurkova LE; Barbanel EIu
Vestn Rentgenol Radiol; 1993; (5):30-1. PubMed ID: 7801580
[TBL] [Abstract][Full Text] [Related]
40. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
Jacobs IJ; Oram DH; Bast RC
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
